Into the Weeds of Refractive Screening
By Christine Yue Leonard, Senior Associate Editor H olding safety paramount to efficacy is the overarching principle for determining whether a patient is a candidate for corneal-based refractive surgery, according to Gaurav Prakash, MD, an assistant professor of ophthalmology at the University of Pittsburgh School of Medicine. “You will have some patients who are borderline, and you may have to say ‘no’ or offer something else,” he says. “That said, if I randomly see 100 patients, about 60 to 70 percent